Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A Multicenter, Randomized, Double-Blind, Active-Controlled Study to Evaluate the Durability of the Efficacy and Safety of Alogliptin Compared to Glipizide When Used in Combination With Metformin in Subjects With Type 2 Diabetes
alogliptin
SYR-322_305
NCT00856284
Type 2 Diabetes Mellitus
Phase 3
 
February 2016

Powered by ideaPoint, Inc.